| Bendamustine investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 118show all (up to 200) |
|---|
| → investigated in trials for | Chronic Lymphocytic Leukemiahematologic_malignancy 56 trials (13 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Chronic Lymphocytic Leukemia | 56 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mantle Cell Lymphomahematologic_malignancy 37 trials (14 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Mantle Cell Lymphoma | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Non-Hodgkin Lymphomahematologic_malignancy 35 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Non-Hodgkin Lymphoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Follicular Lymphomahematologic_malignancy 32 trials (16 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Follicular Lymphoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Multiple Myelomahematologic_malignancy 29 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Multiple Myeloma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lymphomacancer_family 28 trials (8 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lymphoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Small Lymphocytic Lymphoma 23 trials (8 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Small Lymphocytic Lymphoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Diffuse Large B-Cell Lymphoma 22 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Diffuse Large B-Cell Lymphoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hodgkin Lymphomahematologic_malignancy 17 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Hodgkin Lymphoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Marginal Zone Lymphoma 16 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Marginal Zone Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leukemia 11 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Leukemia | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adult Hodgkin Lymphoma 9 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Adult Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Waldenstrom Macroglobulinemia 9 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Waldenstrom Macroglobulinemia | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | B-Cell Malignant Neoplasm 8 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | B-Cell Malignant Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acute Myeloid Leukemia 7 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Acute Myeloid Leukemia | 7 | Observed | clinicaltrials | graph → |